125 related articles for article (PubMed ID: 27105782)
1. The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier.
Luo J; Liu XL; Zhang Y; Wang YQ; Xu WM; Yang J
Am J Reprod Immunol; 2016 Jun; 75(6):643-53. PubMed ID: 27105782
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity study of plasmid DNA encoding mouse cysteine-rich secretory protein-1 (mCRISP1) as a contraceptive vaccine.
Luo J; Yang J; Cheng Y; Li W; Yin TL; Xu WM; Zou YJ
Am J Reprod Immunol; 2012 Jul; 68(1):47-55. PubMed ID: 22429321
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
Chehelgerdi M; Doosti A
J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.
Huang T; Song X; Jing J; Zhao K; Shen Y; Zhang X; Yue B
J Nanobiotechnology; 2018 Jan; 16(1):8. PubMed ID: 29378591
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Chitosan-α-casein Nanoparticles for Improved Gene Delivery: Characterization, Stability, and Transfection Efficiency.
Panão Costa J; Carvalho S; Jesus S; Soares E; Marques AP; Borges O
AAPS PharmSciTech; 2019 Feb; 20(3):132. PubMed ID: 30820699
[TBL] [Abstract][Full Text] [Related]
7. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum.
Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H
J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187
[TBL] [Abstract][Full Text] [Related]
8. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.
Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J
Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity and transfection efficiency of pDNA encoded p53 gene-loaded chitosan-sodium deoxycholate nanoparticles.
Hashem FM; Nasr M; Khairy A; Alqurshi A
Int J Nanomedicine; 2019; 14():4123-4131. PubMed ID: 31239671
[No Abstract] [Full Text] [Related]
10. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
13. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.
Zhao K; Zhang Y; Zhang X; Li W; Shi C; Guo C; Dai C; Chen Q; Jin Z; Zhao Y; Cui H; Wang Y
Int J Nanomedicine; 2014; 9():389-402. PubMed ID: 24426783
[TBL] [Abstract][Full Text] [Related]
14. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
[TBL] [Abstract][Full Text] [Related]
15. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
Özbaş-Turan S; Akbuğa J
Drug Deliv; 2011 Apr; 18(3):215-22. PubMed ID: 21226549
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and characterization of chitosan-DNA nanoparticles as gene carriers].
Su D; Ji AM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):595-8. PubMed ID: 17545064
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
18. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
Mehrabi M; Dounighi NM; Rezayat Sorkhabadi SM; Doroud D; Amani A; Khoobi M; Ajdary S; Pilehvar-Soltanahmadi Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):230-240. PubMed ID: 29260901
[TBL] [Abstract][Full Text] [Related]
19. Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential.
Xiang RL; Zhou F; Yang Y; Peng JP
Biol Reprod; 2003 May; 68(5):1518-24. PubMed ID: 12606447
[TBL] [Abstract][Full Text] [Related]
20. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells.
Hallaj-Nezhadi S; Valizadeh H; Dastmalchi S; Baradaran B; Jalali MB; Dobakhti F; Lotfipour F
J Pharm Pharm Sci; 2011; 14(2):181-95. PubMed ID: 21733408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
